Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|
| Revenue | 112.31bn | 144.46bn | 123.85bn | 45.29bn |
| Cost of revenue | 91.33bn | 114.80bn | 96.35bn | 36.50bn |
| Gross profit | 20.99bn | 29.66bn | 27.50bn | 8.79bn |
| Research and development | 11.31bn | 1.52bn | 10.59bn | 6.78bn |
| Selling, general and administrative | 10.66bn | 1.68bn | 9.77bn | 5.67bn |
| Operating expenses | 21.51bn | 3.10bn | 20.09bn | 12.45bn |
| Operating income | −521m | 7.02bn | 7.41bn | −3.65bn |
| Pre-tax income | 1.30bn | 1.28bn | 10.45bn | −2.16bn |
| Income tax | 158m | 174m | −1.36bn | −127m |
| Net income | 1.12bn | 8.03bn | 11.70bn | −2.01bn |
| Earnings per share | 0.56 | 4.03 | 5.95 | −1.04 |
| Earnings per share, diluted | 0.54 | 3.79 | 5.55 | −1.04 |
| Weighted average shares | 2.02bn | 1.99bn | 1.97bn | 1.94bn |
| Weighted average shares, diluted | 2.14bn | 2.13bn | 2.12bn | 1.94bn |
| Metric | Aug 19, 2026 | Aug 18, 2026 | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | — | — | 56.69bn | 65.90bn | 91.33bn | — | — |
| Receivables | — | — | 120m | 135m | 144m | — | — |
| Inventory | — | — | 8.75bn | 8.19bn | 6.87bn | — | — |
| Current assets | — | — | 115.29bn | 17.30bn | 114.53bn | — | — |
| Goodwill | — | — | 5m | 5m | 5m | — | — |
| Total assets | — | — | 154.30bn | 22.24bn | 143.47bn | — | — |
| Current liabilities | — | — | 63.55bn | 69.22bn | 72.74bn | — | — |
| Short-term debt | — | — | 6.22bn | 281m | 6.98bn | — | — |
| Long-term debt | — | — | 3.30bn | 8.15bn | 1.75bn | — | — |
| Total liabilities | — | — | 81.16bn | 12.47bn | 82.89bn | — | — |
| Equity | — | — | 72.62bn | 9.71bn | 60.14bn | 45.19bn | 41.06bn |
| Shares outstanding | — | — | 2.03bn | 2.01bn | 1.99bn | — | — |
| Shares issued | — | — | 2.03bn | 2.01bn | 1.99bn | — | — |
| Metric | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|
| Operating cash flow | −8.61bn | 2.18bn | 50.69bn | 7.38bn |
| Depreciation and amortisation | 4.64bn | 419m | 1.81bn | 1.21bn |
| Share-based compensation | 1.26bn | 360m | 2.38bn | 2.05bn |
| Capital expenditure | 4.21bn | 7.73bn | 6.51bn | 5.13bn |
| Investing cash flow | −703m | −41.14bn | −12m | −4.36bn |
| Financing cash flow | 767m | −416m | 185m | 5.64bn |
Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)